Acorn Capital Advisors
Acorn Capital Advisors reported 20 stocks worth $366M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CGON (21.9%), URGN (16.8%) and TRVI (10.9%). Compared with Q1 2026, the fund opened new positions in ENGN, added to JBIO, KPTI and AURA, trimmed QTTB and BCAB and sold out of CRDF and XFOR.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 7 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  CGON CG Oncology Inc | $80.4M | 21.9% | 1.1M | No change | 7 of 7 | |
| 2 |  URGN Urogen Pharma Ltd | $61.6M | 16.8% | 1.7M | No change | 7 of 7 | |
| 3 |  TRVI Trevi Therapeutics Inc | $40M | 10.9% | 2.1M | No change | 7 of 7 | |
| 4 |  CADL Candel Therapeutics Inc | $36M | 9.8% | 3.5M | No change | 7 of 7 | |
| 5 |  PBYI Puma Biotechnology Inc | $33.5M | 9.1% | 4.1M | No change | 7 of 7 | |
| 6 |  JBIO Jade Biosciences Inc | $21.9M | 6.0% | 987K | +200K (+25%) | 2 of 7 | |
| 7 |  BCAX Bicara Therapeutics Inc | $19.1M | 5.2% | 643K | No change | 7 of 7 | |
| 8 |  KPTI Karyopharm Therapeutics Inc | $14.8M | 4.0% | 1.5M | +1.2M (+427%) | 2 of 7 | |
| 9 |  OKUR Onkure Therapeutics Inc | $12.9M | 3.5% | 2.8M | No change | 7 of 7 | |
| 10 | CYBIN INC | $10.2M | 2.8% | 1.5M | No change | 7 of 7 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Reported value
last 7 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Acorn Capital Advisors 13F FAQ
What does Acorn Capital Advisors own?
Acorn Capital Advisors reported 20 stocks worth $366M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are CGON (21.9%), URGN (16.8%) and TRVI (10.9%). The table above lists every position in the filing (the top 10 without an account).
What did Acorn Capital Advisors buy and sell in Q2 2026?
Compared with Q1 2026: 1 new positions, 4 added to, 2 trimmed and 3 sold out. New positions include ENGN. It sold all of CRDF and XFOR.
When will Acorn Capital Advisors file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Acorn Capital Advisors's portfolio worth?
The Q2 2026 filing reports $366M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.